Edwards Lifesciences Corporation
EW
Rank in Stocks
#481
Edwards Lifesciences Corporation is a global medical technology firm... Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Share Price
$86.90
Market Cap
$50.09B
Change (1 day)
0.50%
Change (1 year)
16.42%
Country
US
Trade Edwards Lifesciences Corporation (EW)
Category
Healthcare
Number of shares outstanding for Edwards Lifesciences Corporation (EW)
Number of shares outstanding as of June 2026: 576.40M
According to Edwards Lifesciences Corporation latest financial reports and stock price the company's current number of shares outstanding is 576.40M. At the end of December 2024 the company had 597.70M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Edwards Lifesciences Corporation (EW) from 2000 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 576.40M | -1.44% |
| 2025 | 584.80M | -2.16% |
| 2024 | 597.70M | -1.48% |
| 2023 | 606.70M | -1.99% |
| 2022 | 619.00M | -0.69% |
| 2021 | 623.30M | 0.11% |
| 2020 | 622.60M | -0.37% |
| 2019 | 624.90M | -0.43% |
| 2018 | 627.60M | -0.81% |
| 2017 | 632.70M | -0.99% |
| 2016 | 639.00M | -1.16% |
| 2015 | 646.50M | 1.17% |
| 2014 | 639.00M | -4.66% |
| 2013 | 670.20M | -2.79% |
| 2012 | 689.40M | 0.26% |
| 2011 | 687.60M | 0.79% |
| 2010 | 682.20M | 0.98% |
| 2009 | 675.60M | 0.90% |
| 2008 | 669.60M | -2.62% |
| 2007 | 687.60M | -2.05% |
| 2006 | 702.00M | -1.85% |
| 2005 | 715.20M | 0.00% |
| 2004 | 715.20M | 0.85% |
| 2003 | 709.20M | 0.17% |
| 2002 | 708.00M | 0.17% |
| 2001 | 706.80M | 1.40% |
| 2000 | 697.07M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 1.74B | 202.40% |
US
|
|
| 1.28B | 122.43% |
IE
|
|
| 383.50M | -33.47% |
US
|
|
| 1.48B | 156.35% |
US
|
|
| - | - |
DE
|
